AstronauTx is a biotechnology company targeting the biology of sleep architecture as a therapeutic approach to treat neurological disease.
Our novel approach is built on growing evidence that disruption of sleep architecture is a driver of neurodegeneration and that sleep is a disease modifying therapeutic target.
Pipeline
We are advancing two differentiated small molecule programs through IND-enabling studies for: mild cognitive impairment and early Alzheimer’s disease, and REM behavioral disorder (RBD) / prodromal Parkinson’s disease (PD).
Team
AstronauTx is lead by an internationally experienced neuroscientist team of drug developers and sleep physiologsts.
Our mission is to recapitulate the sleep architecture of a healthy young adult to reverse the symptoms and delay the onset and progresson of cognitive decline. Ultimately, we aspire to change the way the brain ages and to extend cognitive vitality to match human lifespan.
